Relmada Therapeutics Statistics
Total Valuation
RLMD has a market cap or net worth of $109.83 million. The enterprise value is $39.40 million.
Important Dates
The next estimated earnings date is Wednesday, November 6, 2024, after market close.
Earnings Date | Nov 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
RLMD has 30.17 million shares outstanding. The number of shares has increased by 0.11% in one year.
Shares Outstanding | 30.17M |
Shares Change (YoY) | +0.11% |
Shares Change (QoQ) | +0.14% |
Owned by Insiders (%) | 8.77% |
Owned by Institutions (%) | 45.03% |
Float | 27.53M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.79 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.44
Current Ratio | 7.44 |
Quick Ratio | 7.39 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -100.40% and return on invested capital (ROIC) is -66.05%.
Return on Equity (ROE) | -100.40% |
Return on Assets (ROA) | -59.13% |
Return on Capital (ROIC) | -66.05% |
Revenue Per Employee | n/a |
Profits Per Employee | -$4.34M |
Employee Count | 20 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Dividends & Yields
RLMD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.11% |
Shareholder Yield | -0.11% |
Earnings Yield | -79.00% |
FCF Yield | -43.87% |
Analyst Forecast
The average price target for RLMD is $7.50, which is 106.04% higher than the current price. The consensus rating is "Hold".
Price Target | $7.50 |
Price Target Difference | 106.04% |
Analyst Consensus | Hold |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on September 30, 2019. It was a reverse split with a ratio of 0.25:1.
Last Split Date | Sep 30, 2019 |
Split Type | Reverse |
Split Ratio | 0.25:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |